Trial intelligence / Profile preview

PROMPT

NCT05128071Phase 1Completed

Sponsor
University of Utah
Start
Feb 2022
Primary completion
May 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Progesterone Arm with Placebo Arm (2 arms). Primary endpoint: Successful Recruitment and Randomization of 40 Postpartum Women Into the PROMPT Study at 15 months. Started Feb 2022; status: completed.

02

Drugs

progesterone
03

Conditions

methamphetamine use disorder (MUD)

Beyond the preview

Go deeper on NCT05128071.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05128071.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call